Eli Lilly Profit Margins 2006-2018 | LLY

Current and historical gross, operating and net profit margins for Eli Lilly (LLY) over the last 10 years. The current net profit margin for Eli Lilly (LLY) as of March 31, 2018 is 4.82%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.417B $22.871B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.885B 16.15
Pfizer (PFE) United States $222.399B 13.69
Novartis AG (NVS) Switzerland $187.250B 16.06
Merck (MRK) United States $168.539B 15.06
AbbVie (ABBV) United States $142.740B 14.56
Novo Nordisk (NVO) Denmark $121.712B 20.17
Sanofi (SNY) France $105.114B 13.31
GlaxoSmithKline (GSK) United Kingdom $100.888B 13.79
AstraZeneca (AZN) United Kingdom $93.793B 9.82
Bristol-Myers Squibb (BMY) United States $92.417B 18.18